BioSpace News Archive

Business

Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO

Sera Prognostics Inc., The Pregnancy Company®, focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, announced the retirement of the Company’s President and CEO, Gregory C. Critchfield, M.D., M.S.

May 15, 2023
·
6 min read
Deals

ERYTECH Provides Update on the Announced Combination with PHERECYDES

ERYTECH Pharma,aclinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, provided anupdateon the announced combination with PHERECYDES.

May 15, 2023
·
9 min read
Business

SeaStar Medical Reports First Quarter 2023 Financial Results and Provides a Business Update

SeaStar Medical Holding Corporation reports financial results for the three months ended March 31, 2023 and provides a business update.

May 15, 2023
·
13 min read
Business

Bellerophon Provides Clinical Program Update and Reports First Quarter 2023 Financial Results

Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon” or the “Company”), a clinical-stage biotherapeutics company focused on developing treatments for cardiopulmonary diseases, today provided a clinical program update and reported financial results for the first quarter ended March 31, 2023.

May 15, 2023
·
7 min read
Business

9 Meters Biopharma Provides Business Update and Reports Financial Results for First Quarter 2023

9 Meters Biopharma, Inc., a clinical-stage company pioneering novel treatments for people with rare or debilitating digestive diseases, provided a business update and announced financial results for the first quarter ended March 31, 2023.

May 15, 2023
·
5 min read